First Horizon Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9K | Buy |
110
+6
| +6% | +$748 | ﹤0.01% | 1556 |
|
|
2025
Q1 | $14.2K | Buy |
104
+4
| +4% | +$572 | ﹤0.01% | 1461 |
|
|
2024
Q4 | $15.3K | Sell |
100
-82
| -45% | -$13.8K | ﹤0.01% | 1434 |
|
|
2024
Q3 | $35.3K | Buy |
182
+10
| +6% | +$2.09K | ﹤0.01% | 1142 |
|
|
2024
Q2 | $39.9K | Buy |
172
+49
| +40% | +$10.6K | ﹤0.01% | 1014 |
|
|
2024
Q1 | $26.5K | Sell |
123
-88
| -42% | -$20.6K | ﹤0.01% | 1230 |
|
|
2023
Q4 | $54.6K | Sell |
211
-67
| -24% | -$16.5K | ﹤0.01% | 898 |
|
|
2023
Q3 | $71.4K | Sell |
278
-460
| -62% | -$123K | ﹤0.01% | 722 |
|
|
2023
Q2 | $210K | Sell |
738
-83
| -10% | -$24.7K | 0.01% | 465 |
|
|
2023
Q1 | $228K | Sell |
821
-134
| -14% | -$37.1K | 0.01% | 449 |
|
|
2022
Q4 | $264K | Sell |
955
-531
| -36% | -$150K | 0.01% | 404 |
|
|
2022
Q3 | $396K | Buy |
1,486
+20
| +1% | +$4.25K | 0.02% | 335 |
|
|
2022
Q2 | $298K | Sell |
1,466
-3,929
| -73% | -$803K | 0.01% | 398 |
|
|
2022
Q1 | $1.14M | Sell |
5,395
-12,007
| -69% | -$2.61M | 0.06% | 216 |
|
|
2021
Q4 | $4.17M | Sell |
17,402
-950
| -5% | -$244K | 0.13% | 188 |
|
|
2021
Q3 | $5.19M | Buy |
18,352
+866
| +5% | +$284K | 0.17% | 163 |
|
|
2021
Q2 | $6.05M | Sell |
17,486
-187
| -1% | -$56.6K | 0.33% | 92 |
|
|
2021
Q1 | $4.94M | Buy |
17,673
+466
| +3% | +$126K | 0.29% | 97 |
|
|
2020
Q4 | $4.21M | Sell |
17,207
-328
| -2% | -$84.6K | 0.28% | 99 |
|
|
2020
Q3 | $4.97M | Sell |
17,535
-52
| -0.3% | -$14.5K | 0.37% | 79 |
|
|
2020
Q2 | $4.71M | Buy |
17,587
+146
| +0.8% | +$43.9K | 0.37% | 77 |
|
|
2020
Q1 | $5.52M | Sell |
17,441
-458
| -3% | -$139K | 0.52% | 59 |
|
|
2019
Q4 | $5.31M | Sell |
17,899
-513
| -3% | -$142K | 0.39% | 73 |
|
|
2019
Q3 | $4.29M | Buy |
18,412
+3,097
| +20% | +$721K | 0.33% | 91 |
|
|
2019
Q2 | $3.58M | Buy |
15,315
+449
| +3% | +$104K | 0.28% | 104 |
|
|
2019
Q1 | $3.51M | Buy |
14,866
+956
| +7% | +$301K | 0.28% | 105 |
|
|
2018
Q4 | $4.18M | Sell |
13,910
-1,605
| -10% | -$512K | 0.37% | 67 |
|
|
2018
Q3 | $5.48M | Sell |
15,515
-401
| -3% | -$138K | 0.43% | 73 |
|
|
2018
Q2 | $4.62M | Buy |
15,916
+64
| +0.4% | +$18K | 0.39% | 77 |
|
|
2018
Q1 | $4.32M | Sell |
15,852
-710
| -4% | -$220K | 0.42% | 73 |
|
|
2017
Q4 | $5.33M | Sell |
16,562
-259
| -2% | -$83.1K | 0.51% | 67 |
|
|
2017
Q3 | $5.28M | Sell |
16,821
-106
| -0.6% | -$31.4K | 0.54% | 62 |
|
|
2017
Q2 | $4.64M | Buy |
16,927
+885
| +6% | +$234K | 0.51% | 66 |
|
|
2017
Q1 | $4.38M | Buy |
16,042
+893
| +6% | +$252K | 0.5% | 68 |
|
|
2016
Q4 | $4.68M | Hold |
15,149
| – | – | 0.6% | 62 |
|
|
2016
Q3 | $4.68M | Buy |
15,149
+500
| +3% | +$148K | 0.6% | 62 |
|
|
2016
Q2 | $3.54M | Sell |
14,649
-797
| -5% | -$210K | 0.48% | 85 |
|
|
2016
Q1 | $4.03M | Buy |
15,446
+2,572
| +20% | +$679K | 0.45% | 79 |
|
|
2015
Q4 | $3.94M | Sell |
12,874
-482
| -4% | -$139K | 0.7% | 54 |
|
|
2015
Q3 | $3.9M | Buy |
13,356
+300
| +2% | +$99.1K | 0.6% | 65 |
|
|
2015
Q2 | $5.27M | Buy |
13,056
+165
| +1% | +$66.2K | 0.77% | 40 |
|
|
2015
Q1 | $5.46M | Buy |
12,891
+5,816
| +82% | +$2.29M | 0.79% | 33 |
|
|
2014
Q4 | $2.4M | Buy |
7,075
+5,719
| +422% | +$1.85M | 0.37% | 93 |
|
|
2014
Q3 | $448K | Buy |
1,356
+472
| +53% | +$156K | 0.07% | 215 |
|
|
2014
Q2 | $279K | Buy |
884
+735
| +493% | +$221K | 0.04% | 287 |
|
|
2014
Q1 | $44K | Sell |
149
-28
| -16% | -$8.89K | 0.01% | 539 |
|
|
2013
Q4 | $50K | Buy |
177
+98
| +124% | +$25.3K | 0.01% | 485 |
|
|
2013
Q3 | $19K | Buy |
79
+26
| +49% | +$5.82K | ﹤0.01% | 671 |
|
|
2013
Q2 | $11K | Buy |
+53
| New | +$11.3K | 0.01% | 492 |
|
Other funds holding BIIB
First Horizon Advisors's BIIB Position: Q2 2025 in Review
First Horizon Advisors increased its Biogen (BIIB) stake by 5.8% in Q2 2025, buying an estimated $748 and bringing the position to 110 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1556.
First Horizon Advisors first reported a position in BIIB in Q2 2013 and has held it in 49 quarters since. The position peaked at $6.05M in Q2 2021. 867 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.
- First Horizon Advisors held 110 shares of Biogen worth $13.9K as of Q2 2025.
- First Horizon Advisors bought 6 Biogen shares in Q2 2025, an estimated $748.
- Biogen made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1556 holding.
- First Horizon Advisors first reported a position in Biogen in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's Biogen position peaked at $6.05M in Q2 2021.
- 867 funds tracked by Wall St. Rank held Biogen as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.